SSX8P

Across TCGA pan-cancer cohorts, SSX8P Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated SSX8P data layer compared with 14 for mass-spec protein.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher SSX8P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated SSX8P expression acts as an unfavorable survival marker.

BLCA, BRCA, and GBM are the cancer types where SSX8P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	All	0.197	0.720	.004	18	view →
BRCA	DFS	Median	All	0.358	0.903	<.001	12	view →
GBM	OS	Median	All	0.075	0.413	.003	6	view →
COAD	DFS	Median	II,III,IV	0.279	0.664	.045	3	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

SSX8P–BLCA (OS)

Open the BLCA breakdown →